News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
Heidelberg Pharma progresses into Cohort 6 with ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study, showing first objective responses and partial remissions. Amended protocol includes optimized dosing regimens -
COMMUNIQUÉ DE PRESSE
Publication of Annual Report 2023, Sustainability Report 2023, Business Review 2023; update on climate strategy
Julius Baer Group releases Annual Report 2023, Sustainability Report 2023, Business Review 2023, and updates on climate strategy, emphasizing net-zero emissions targets and sustainability efforts -
-
COMMUNIQUÉ DE PRESSE
Partners Group adds private markets royalties to its investment platform
Partners Group adds private markets royalties as fifth asset class, aiming to target a fast-growing market worth over USD 1 trillion. The firm's new royalty strategy offers attractive risk-adjusted returns and diversification benefits
